MyMyelomaTeam

Revlimid (lenalidomide) is commonly used in combination with other medications, particularly during initial treatment. The most common combination includes bortezomib (Velcade) and dexamethasone (a corticosteroid) during induction therapy. However, Revlimid can be used alone as maintenance therapy after stem cell Show Full Answer

Revlimid (lenalidomide) is commonly used in combination with other medications, particularly during initial treatment. The most common combination includes bortezomib (Velcade) and dexamethasone (a corticosteroid) during induction therapy. However, Revlimid can be used alone as maintenance therapy after stem cell transplant. Studies show that maintenance therapy with Revlimid alone can help sustain remission for approximately 57 months, compared to 30 months without maintenance treatment.

Common side effects to watch for include:
- Diarrhea or constipation
- Fatigue
- Swelling in extremities
- Sleep problems
- Muscle cramps
- Digestive issues
- Rash

Always discuss any side effects with your healthcare team as they can help manage these symptoms.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

6 Refractory Myeloma Treatment Options: First Line, CAR T Cells, and More

Multiple Myeloma Maintenance Therapy: 6 Facts